Patient Square Capital’s Pharvaris PHVS Stock Holding History

Patient Square Capital’s Portfolio PHVS Stock Details PHVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$23.2M	Buy	671,209 +178,209	+36%	+$5.39M	3.6%	6
2026 Q1	$13.9M	Sell	493,000 -49,696	-9%	-$1.33M	2.47%	11
2025 Q4	$15.1M	Buy	542,696 +197,315	+57%	+$4.75M	3.22%	7
2025 Q3	$8.62M	Buy	345,381 +101,098	+41%	+$2.24M	2.31%	8
2025 Q2	$4.3M	Sell	244,283 -1,213	-0.5%	-$19.5K	1.55%	14
2025 Q1	$3.85M	Buy	245,496 +37,893	+18%	+$639K	1.59%	14
2024 Q4	$3.98M	Sell	207,603 -34,738	-14%	-$715K	1.49%	12
2024 Q3	$4.49M	Buy	+242,341	New	+$4.43M	1.67%	7

Other funds holding PHVS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return

FCMI

Foresite Capital Management IV Larkspur, California $290M AUM 143.88% 1-Year Est. Return

venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

EFM

EQT Fund Management Luxembourg $863M AUM 26.03% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Patient Square Capital's PHVS Position: Q2 2026 in Review

Patient Square Capital increased its Pharvaris (PHVS) stake by 36% in Q2 2026, buying an estimated $5.39M and bringing the position to 671,209 shares worth $23.2M. The position accounts for 3.6% of the portfolio, ranked #6.

Patient Square Capital first reported a position in PHVS in Q3 2024 and has held it in 8 quarters since. 125 funds tracked by Wall St. Rank hold PHVS as of Q2 2026.

Patient Square Capital held 671,209 shares of Pharvaris worth $23.2M as of Q2 2026.
Patient Square Capital bought 178,209 Pharvaris shares in Q2 2026, an estimated $5.39M.
Pharvaris made up 3.6% of Patient Square Capital's portfolio in Q2 2026, its #6 holding.
Patient Square Capital first reported a position in Pharvaris in Q3 2024 and has held it in 8 quarters since.
125 funds tracked by Wall St. Rank held Pharvaris as of Q2 2026.

Based on Patient Square Capital's 13F filing for Q2 2026, filed 12 Aug 2026.